GenNext Technologies, Inc., develops instrumentation, software, and services that help scientists understand and optimize the structure and behavior of therapeutic proteins. The company’s patented protein footprinting technology enables faster, safer, and more reproducible structural analysis—empowering researchers to accelerate drug development and improve therapeutic outcomes.